Immune Management ApS: Financial statements 2020
CVR: 38726137
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Immune Management ApS (CVR 38726137) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -16,722 and a net result of DKK -116,564 compared with DKK 98,704 the year before. Equity in the 2020 report amounted to DKK 229,600. The solvency ratio was 94.1%.
- Gross Profit
- DKK -16,722
- Profit/Loss
- DKK -116,564
- Equity
- DKK 229,600
- Total Assets
- DKK 243,972
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -17K | -117K | 230K | 0 |
| 2019 | - | 621K | 99K | 401K | - |
| 2018 | - | 500K | -55K | 303K | 1 |
| 2017 | - | 818K | 111K | 358K | 1 |
Official annual report
How creditworthy is Immune Management ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Immune Management ApS has published its annual report for 2019. Gross profit came to DKK 621,142, and the net result was DKK 98,704.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.